Pharmacognosy Unit I
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clinical Uses and Toxicity of Ephedra Sinica: an Evidence-Based Comprehensive Retrospective Review (2004–2017)
Pharmacogn J. 2019; 11(1): 447-452 A Multifaceted Journal in the field of Natural Products and Pharmacognosy Review Article www.phcogj.com | www.journalonweb.com/pj | www.phcog.net Clinical uses and Toxicity of Ephedra sinica: An Evidence-Based Comprehensive Retrospective Review (2004–2017) Walaa Al saeed1, Marwa Al Dhamen1, Rizwan Ahmad2*, Niyaz Ahmad3, Atta Abbas Naqvi4 ABSTRACT Background: Ephedra sinica (ES) (Ma-huang) is a well-known plant due to its widespread therapeutic uses. However, many adverse effects such as hepatitis, nephritises, and cardio- vascular toxicity have been reported for this plant. Few of these side effects are reversible whereas others are irreversible and may even lead to death. Aim of the Study: The aim of this study was to investigate the clinical uses and toxicity cases/consequences associated 1 Walaa Al saeed , Marwa Al with the use of ES. The review will compare and evaluate the cases reported for ES and identify Dhamen1, Rizwan Ah- the causes which make the plant a poisonous one. Materials and Methods: An extensive mad2*, Niyaz Ahmad3, Atta literature review was conducted from 2004 to 2017, and research literature regarding the Abbas Naqvi4 clinical cases were collected using databases and books such as Google Scholar, Science Direct, Research gate, PubMed, and Web of Science/Thomson Reuters whereas the keywords 1College of Clinical Pharmacy, Imam searched were “Ephedra sinica,” clinical cases of Ephedra sinica, “Ma-hung poisonous,” Abdulrahman Bin Faisal University, “Ma-hung toxicity reported cases and treatment,” and “Ephedra Sinica toxicity reported cases Dammam, SAUDI ARABIA. and treatment.” Results: eleven different cases were identified which met the eligibility criteria 2Natural Products and Alternative Medi- and were studied in detail to extract out the findings. -
Phytochemistry, Pharmacology and Agronomy of Medicinal Plants: Amburana Cearensis, an Interdisciplinary Study
17 Phytochemistry, Pharmacology and Agronomy of Medicinal Plants: Amburana cearensis, an Interdisciplinary Study Kirley M. Canuto, Edilberto R. Silveira, Antonio Marcos E. Bezerra, Luzia Kalyne A. M. Leal and Glauce Socorro B. Viana Empresa Brasileira de Pesquisa Agropecuária, Universidade Federal do Ceará, Brazil 1. Introduction Plants are an important source of biologically active substances, therefore they have been used for medicinal purposes, since ancient times. Plant materials are used as home remedies, in over-the-counter drug products, dietary supplements and as raw material for obtention of phytochemicals. The use of medicinal plants is usually based on traditional knowledge, from which their therapeutic properties are oftenly ratified in pharmacological studies. Nowadays, a considerable amount of prescribed drug is still originated from botanical sources and they are associated with several pharmacological activities, such as morphine (I) (analgesic), scopolamine (II) atropine (III) (anticholinergics), galantamine (IV) (Alzheimer's disease), quinine (V) (antimalarial), paclitaxel (VI), vincristine (VII) and vinblastine (VIII) (anticancer drugs), as well as with digitalis glycosides (IX) (heart failure) (Fig. 1). The versatility of biological actions can be attributed to the huge amount and wide variety of secondary metabolites in plant organisms, belonging to several chemical classes as alkaloids, coumarins, flavonoids, tannins, terpenoids, xanthones, etc. The large consumption of herbal drugs, in spite of the efficiency of -
Pharmacognosy, Phytochemical Study and Antioxidant Activity of Sterculia Rubiginosa Zoll
Pharmacogn J. 2018; 10(3):571-575. A Multifaceted Journal in the field of Natural Products and Pharmacognosy Original Article www.phcogj.com | www.journalonweb.com/pj | www.phcog.net Pharmacognosy, Phytochemical Study and Antioxidant Activity of Sterculia rubiginosa Zoll. Ex Miq. Leaves Rini Prastiwi1,2*, Berna Elya2, Rani Sauriasari3, Muhammad Hanafi4, Ema Dewanti1 ABSTRACT Introduction: Sterculia rubiginosa Zoll ex.Miq leaves have been used as traditional medicine in Indonesia. There is no report about pharmacognosy and phytochemical study with this plant.Objective: The main aim of this research is to establish pharmacognosy, phytochemical study and antioxidant activity of Sterculia rubiginosa Zoll.ex. Miq. Leaves. The plant used to cure many diseases of Indonesia. Methods: In the present study, pharmacognosy and phyto- 1,2* chemical study of plant material were performed as per the Indonesian Herb Pharmacopoeia. Rini Prastiwi , Berna Results: Microscopy powder of Sterculia rubiginosa Zoll.ex. Miq. Leaves shows star shape Elya2, Rani Sauriasari3, trichoma as a specific fragment. Physicochemical parameters including total ash (17.152 %), Muhammad Hanafi4, acid-insoluble ash (0.922 %), water-soluble extractive (1.610 % w/w), alcohol-soluble extractive Ema Dewanti1 (4.524 % w/w), hexane-soluble extractive (4.005 % w/w), and ethyl acetate-soluble extractive (3.160 % w/w) were evaluated. Phytochemical screening of ethanol extracts showed the 1Department of Pharmacognosy- presence of tannins, flavonoids, alkaloids, steroids-terpenoids, glycosides, and phenols. And Phytochemistry, Faculty of Pharmacy absent of saponins and Anthraquinones. Antioxidant activity with IC50 157, 4665 ppm and and Science Muhammadiyah Prof.Dr. flavonoid total was 59.436 mg/g quercetin equivalent. -
Sources of Crude Drug, Plant Families, Biogenesis of Phytochemicals
1 Sources of Crude Drug, Plant Families, Biogenesis of Phytochemicals SOURCES OF CRUDE DRUG Plant Oldest source of drugs. 25% of the drugs prescribed worldwide come from plants More than 200 drugs considered as basic and essential by the World Health Organisation (WHO) Significant number of synthetic drugs obtained from natural precursors. Example: Digoxin from Digitalis species, quinine and quinidine from Cinchona species, vincristrine and vinblastine from Catharanthus roseus, atropine from Atropa belladonna and morphine and codeine from Papaver somniferum. Animal Second largest source of crude drugs. Example: Honey from honeybee, beeswax from bees, cod liver oil from shark, bufalin from toad, animal pancreas is a source of Insulin, musk oil from musk, spermaceti wax from sperm whale, woolfat from sheep, carminic acid from colchineal, venoms from snake Mineral Highly purified form of naturally occurring mineral substances is used in medicine Example: Sulphur is a key ingredient in certain bacteriostatic drugs, shilajit is used as tonic, calamine is used as anti-itching agent Marine Major part of earth is covered with water bodies and hence bioactive compounds from marine flora and fauna (microorganisms, algae, fungi, invertebrates, and 1 Contd… 2 Pharmacognosy and Phytochemistry: A Companion Handbook vertebrates) have extensive past and present use in the treatment of many diseases Marine Serve as compounds of interest both in their natural form and as templates for synthetic modification. Several molecules isolated from various -
Review of the Powder and Decoction Formulae in Traditional Chinese
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2015 June 15; 35(3): 355-360 [email protected] ISSN 0255-2922 © 2015 JTCM. All rights reserved. REVIEWTOPIC Review of the powder and decoction formulae in Traditional Chi- nese Medicine based on pharmacologically active substances and clinical evidence Liu Qihua, Wen Jin, Peng Zhiping, Liu Fenglin, Tong Xiaolin aa Liu Qihua, Wen Jin, Peng Zhiping, Tong Xiaolin, Depart- tions; Pharmacology; Medicine, Chinese traditional; ment of Pharmacy and Endocrinology, Guang'an men Hospi- Review tal, China Academy of Chinese Medical Sciences, Beijing 100053, China Liu Fenglin, Department of Medical, Harbin Emergency INTRODUCTION Center, Harbin 150020, China Supported by National Basic Research Program of China Most crude drugs used in Traditional Chinese Medi- (Dose-Effect Relationship Study of Classical famous Prescrip- cine (TCM) are natural products. Some come from en- tion, No. 2010CB530601), Beijing Science Society Project dangered species, which means their supply is very lim- (Common technology Demonstration and Research for Boil- ited and the supply of some crude drugs is constrained ing Powders of Chinese Materia Medica, No. by their exhaustibility. The use of power formulae is an Z121102001112010) effective way to conserve these crude drug resources. Correspondence to: Prof. Tong Xiaolin, Department of En- Study indicates that the use of powder formulae can docrinology, Guang'an men Hospital, China Academy of Chi- save up to two-thirds of each drug used compared with nese Medical Sciences, Beijing 100053, China. -
The Descent of the Flowering Plants in the Light of New Evidence from Phytochemistry and from Other Sources
The descent of the flowering plants in the light of new evidence from phytochemistry and from other sources. I. General discussion A.D.J. Meeuse Hugo de Vries-laboratorium en Hortus Botanicus, Amsterdam SUMMARY Accumulated phytochemical data partially compiled by Kubitzki in 1969, and evidence from various other sources point to a fundamental heterogeneity of the Flowering Plants, which is interpretedby the present author as an unmistakable indication of a multiple descent of the Angiosperms. The consequences of this viewpoint for taxonomic classifications and for phy- In logenetic speculations must be faced. view of the possible misunderstandingof some poin- ters, and in order to avoid erroneous interpretations of the accumulated evidence, a survey of the relevant data be indicated. Some tentative future appears to proposals concerning a classification of the will be made in the second of this Angiosperms part paper. 1. INTRODUCTION 1 Recently, Kubitzki (1969) pointed out that cogent phytochemical evidence renders a close relationship between the Polycarpicae or Ranales(s.l.) and sever- The of his discus- al other groups of the Dicotyledons most unlikely. corollary sion is that the Dicots (and, by inference, the Angiosperms) are rather hetero- geneous and did not all arise from a ranalean ancestral group, and that, in point kind of of fact, the ranalean alliance is more likely to represent a phylogenetic cul-de-sac. Most hesitatingly, Kubitzki admits the possibility of a multiple to statement descent of the Flowering Plants, referring a made over fifteenyears ago by Metcalfe (who suggested that the assumption of a polyphyletic origin of the Angiosperms may well provide the best explanation of the great diversity of their anatomicalfeatures) but, strangely enough, not mentioning more recent contributions dealing with the question of a single versus a multiple descent. -
Pharmacognosy: Science of Natural Products in Drug Discovery Ilkay Erdogan Orhan* Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkey
Orhan, BioImpacts, 2014, 4(3), 109-110 doi: 10.15171/bi.2014.001 TUOMS http://bi.tbzmed.ac.ir/ Publishing BioImpacts Group Editorial Pharmacognosy: Science of natural products in drug discovery Ilkay Erdogan Orhan* Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkey A R T I C L E I N F O Summary AUTHOR B I O S K E T C H Article History: Pharmacognosy deals with the natural drugs obtained from Prof. Dr. Orhan obtained her Received: 15 Sep. 2014 organisms such as most plants, microbes, and animals. Up to PhD degree in Accepted: 21 Sep. 2014 date, many important drugs including morphine, atropine, Pharmacognosy ePublished: 22 Sep. 2014 from Faculty galanthamine, etc. have originated from natural sources which of Pharmacy, continue to be good model molecules in drug discovery. Gazi University, Ankara, Turkey Keywords: Traditional medicine is also a part of pharmacognosy and most in 2002. She is Pharmacognosy of the third world countries still depend on the use of herbal Young Affiliate Representative of Natural products the Central & South Asia region medicines. Consequently, pharmacognosy always keeps its (ROCASA) of Third World Academy Herbal medicine popularity in pharmaceutical sciences and plays a critical role in of Sciences (TWAS) for the period Pharmacy of 2011-2016. She is now affiliated drug discovery. as full professor at Gazi University. Her research interests are inhibitory activity of natural products against enzymes, phytochemistry, and marine natural products. natural product is a chemical substance produced of the prescription drugs dispensed in the United States by living organisms such as plants, mushrooms, contain at least one active ingredient of plant origin.3 animals, and microorganisms. -
Natural Products. a History of Success and Continuing Promise for Drug Discovery and Development
Natural Products. A History of Success and Continuing Promise for Drug Discovery and Development Gordon M. Cragg NIH Special Volunteer [email protected] David J. Newman Natural Products Branch Developmental Therapeutics Program National Cancer Institute EARLY DOCUMENTATION OF USE OF MEDICINAL PLANTS http://www.nlm.nih.gov/hmd/collections/archives/index.html • Mesopotamian ~2,600 B. C. E. • Egyptian ~ 1,800 B. C. E. • Chinese – ~1,100 B. C. E. and continuing • Indian ~ 1,000 B. C. E. and continuing • Greek ~ 500 B. C. E. Greco-Roman expertise preserved and coordinated with other traditions by Islamic cultures during the Dark Ages ~ 400-1,100 CE Avicenna. Persian pharmacist, physician, poet, philosopher author: canon medicinae – “final codification of Greco-Roman medicine” Great Moments in Pharmacy Collection APhA Traditional Medicine and Drug Discovery • 80% of the world population resides in developing countries • 80% of people in developing countries utilize plants to meet their primary health care needs • Global pop. ca. 7 billion ca. 4.5 billion people utilize plants to meet their primary health care needs Farnsworth NR, et al. Medicinal Plants in Therapy. Bull. W.H.O. 63:965-981 (1985) Fabricant and Farnsworth, EnViron. Health Perspect. 109, 69-75 (2001) Cordell and Clovard, J. Nat. Prod., 75, 514-525 (2012) Norman Farnsworth 1800s. Discovery of some active principles of major herbal preparations Newman and Cragg. Natural Product Chemistry for Drug Discovery, eds. Buss and Butler, M. S., Royal Soc. Chem., Cambridge, 2010, pp. 3-27 European chemists (apothecaries) revolutionized drug discovery and development. 1817. Sertϋrner reports isolation of morphine from Papaver somniferum. -
Anatomical and Phytochemical Studies of the Leaves and Roots of Urginea Grandiflora Bak
Ethnobotanical Leaflets 14: 826-35. 2010. Anatomical and Phytochemical Studies of the Leaves and Roots of Urginea grandiflora Bak. and Pancratium tortuosum Herbert H. A. S. Sultan, B. I. Abu Elreish and S. M. Yagi* Department of Botany, Faculty of Science, University of Khartoum, P.O. Box 321, Khartoum, Sudan *Corresponding author E-mail address: [email protected] Issued: July 1, 2010 Abstract Urginea grandiflora Bak. and Pancratium tortuosum Herbert are bulbous, medicinal plants endemic to the Sudan. The aim of this study was to provide information on the anatomical properties of the leaves and roots of these two bulbous plants. Anatomical studies include cross sections of the leaves and roots. In addition, phytochemical screening methods were applied for identifying the major chemical groups in these species. This study provides referential botanical and phytochemical information for correct identification of these plants. Key words: bulbous plants; Urginea grandiflora; Pancratium tortuosum anatomy; phytochemistry. Introduction To ensure reproducible quality of herbal products, proper control of starting material is utmost essential. Thus in recent years there have been an emphasis in standardization of medicinal plants of therapeutic potential. According to World Health Organization (WHO) the macroscopic and microscopic description of a medicinal plant is the first step towards establishing its identity and purity and should be carried out before any tests are undertaken (Anonymous. 1996). Correct botanical identity based on the external morphology is possible when a complete plant specimen is available. Anatomical characters can also help the identification when morphological features are indistinct (David et al., 2008). Urginea grandiflora Bak. (Hyacinthaceae) and Pancratium tortuosum Herbert (Amaryllidaceae) are perennial, herbaceous and bulbous plants, distributed in the Red Sea Hills in Eastern Sudan (Andrews, 1956). -
Pharmacognosy of Plants
nd M y a ed OPEN ACCESS Freely available online g ic lo i o n i e B Biology and Medicine ISSN: 0974-8369 Editorial Pharmacognosy of Plants Mohamed G Elfaki* Scientist, Professor of Microbiology, Department of Infection and Immunity, King Faisal Specialist Hospital and Research Centre, Alfaisal University College of Medicine, Saudi Arabia Pharmacognosy is the think about of plants or other common grown medication, chemistry, biotechnology, phytochemistry, sources as a conceivable source of drugs. The American Society pharmacology, pharmaceutics, clinical drug store and drug store of Pharmacognosy characterizes pharmacognosy as "the ponder practice. of the physical, chemical, biochemical, and organic properties of Medical Ethnobotany: The ponder of the conventional utilize of drugs, medicate substances, or potential drugs or sedate substances plants for restorative purposes. of common beginning as well as the seek for modern drugs from normal sources". The word "pharmacognosy" is inferred from two Ethnopharmacology: The ponder of the pharmacological Greek words pharmakon (medicate), and gnosis (information) or the qualities of conventional therapeutic substances; the consider Latin verb cognosco (con, 'with', and gnosco, 'know'; itself a cognate of phytotherapy (the restorative utilize of plant extricates); and of the Greek verb gignosko, meaning 'I know, perceive'), meaning phytochemistry, the consider of chemicals inferred from plants 'to conceptualize' or 'to recognize'. The term "pharmacognosy" was (counting the recognizable proof of unused medicate candidates utilized for the primary time by the Austrian doctor Schmidt in determined from plant sources). The carotenoids in primrose 1811 and 1815 by Crr. Anotheus Seydler in work titled Analecta create shinning ruddy, yellow and orange shades. -
Proposal for Revival of the Phytochemistry Section at BSA
Proposal for revival of the Phytochemistry section at BSA Phytochemistry is a broad field encompassing the molecular biology, genetics, physiology, ecology, evolution, and applications of plant-associated compounds and their biosynthetic pathways. This area has become an integral part of organismal studies in plant science, as plant chemical diversity plays a central role in ecology and evolution. Moreover, advances in metabolomics and genomics have allowed plant biochemistry to expand into many non-model species. Many of these advances have come in the last decade, during which time the Phytochemistry section of BSA has been inactive. We propose to reinstate the Phytochemistry section to recognize and support the growth in biochemical research across the diversity of plant lineages. The various existing sections of BSA house many areas of expertise that can synergistically function with a new, rejuvenated phytochemistry section. We are especially excited about the cross-pollination of ideas that would be made possible when a greater number of phytochemists attend the BSA meetings, interact with students and faculty from existing sections, and help generate innovative research projects and grant proposal ideas. We thus strongly believe that a revived Phytochemistry section would be timely and very useful for the botanical community moving forward. We imagine the new Phytochemistry section as a home for a broad array of researchers interested in plant physiology, biochemistry, biochemical genomics, metabolic evolution, biotic interactions, chemical ecology and medical ethnobotany. Having this section at BSA would not only provide a home to many existing society members and entice more phytochemists to join BSA, but also provide networking and recognition opportunities for students working in this field. -
An Update Review on Hibiscus Rosa Sinensis Phytochemistry and Wounds
Journal of Ayurvedic and Herbal Medicine 2018; 4(3): 135-146 Review Article An update review on Hibiscus rosa sinensis phytochemistry ISSN: 2454-5023 and medicinal uses J. Ayu. Herb. Med. 2018; 4(3): 135-146 Asmaa Missoum © 2018, All rights reserved Department of Biological and Environmemntal Sciences, College of Arts and sciences, Qatar University (QU), Doha, www.ayurvedjournal.com Qatar Received: 14-08-2018 Accepted: 10-10-2018 ABSTRACT Hibiscus rosa sinensis is known as China rose belonging to the Malvaceae family. This plant has various important medicinal uses for treating wounds, inflamation, fever and coughs, diabetes, infections caused by bacteria and fungi, hair loss, and gastric ulcers in several tropical countries. Phytochemical analysis documented that the main bioactive compounds responsible for its medicinal effects are namely flavonoids, tannins, terpenoids, saponins, and alkaloids. Experiment from recent studies showed that various types of extracts from all H. rosa sinensis parts exhibited a wide range of beneficial effects such as hypotensive, anti-pyritic, anti-inflammatory, anti-cancer, antioxidant, anti-bacterial, anti-diabetic, wound healing, and abortifacient activities. The few studies on toxicity exhibited that most extracts from all parts of this plant did not show any signs of toxicity at higher doses according to histological analysis. However, some of the extracts did alter biochemical and hematological parameters. Therefore, further research must be conducted to isolate the phytochemicals and explore their specific mechanism of action. This review summarizes the phytochemistry, pharmocology, and medicinal uses of this flower with the purpose of finding gaps demanding for future research and investigating its therapeutic potential through clinical trials.